Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Porter, Ross John; Andrews, Caroline; Brice, Daniel Paul; Durum, Scott Kenneth; McLean, Mairi Hall

Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Files

Revised_Manuscript_IBD_Porter_et_al_IBD_D_18_00038_clean_Combined.pdf (626.88 KB)

Date

2018-09-15

Authors

Citation

Porter, R J, Andrews, C, Brice, D P, Durum, S K & McLean, M H 2018, 'Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?', Inflammatory Bowel Diseases, vol. 24, no. 10, pp. 2123-2134. https://doi.org/10.1093/ibd/izy230